{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-090062","form_type":"8-K","ticker":"TEM","cik":"0001717115","company_name":"Tempus AI, Inc.","filed_at":"2025-04-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.455497+00:00","generated_at":"2026-05-23T08:17:28.929152+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tempus AI inks deals with AstraZeneca, Pathos for $200M data licensing, $35M fee for oncology AI model","bullets":["AstraZeneca pays Tempus $35M under MSA for foundational multimodal oncology model developed by Pathos using Tempus de-identified data.","Tempus and Pathos sign Order Form: Pathos pays $200M data license fees over 3 years ($50M upfront); Tempus receives license to use model.","Pathos may pay up to 50% of data license fees in shares of Pathos Series D Preferred Stock at its discretion.","Tempus pays Pathos $35M in consideration for Pathos' commitments under the Pathos Master Agreement.","Syndicate led by AstraZeneca will execute stock purchase agreement with Pathos in preferred stock financing round."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-090062","json":"https://secwatch.observer/filing/0001193125-25-090062.json","markdown":"https://secwatch.observer/filing/0001193125-25-090062.md","text":"https://secwatch.observer/filing/0001193125-25-090062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1717115/000119312525090062/0001193125-25-090062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1717115/000119312525090062/d944168d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T08:17:28.929152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}